Cunningham, D., Falk, S., & Jackson, D. (2002). Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer. Nature Publishing Group.
Citação norma ChicagoCunningham, D., S. Falk, and D. Jackson. Clinical and Economic Benefits of Irinotecan in Combination With 5-fluorouracil and Folinic Acid As First Line Treatment of Metastatic Colorectal Cancer. Nature Publishing Group, 2002.
Citação norma MLACunningham, D., S. Falk, and D. Jackson. Clinical and Economic Benefits of Irinotecan in Combination With 5-fluorouracil and Folinic Acid As First Line Treatment of Metastatic Colorectal Cancer. Nature Publishing Group, 2002.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.